Category: Drug Discovery
Global Drug Discovery
-
Lifestyle Drugs Market by Therapeutic Type (Dermatology, Insomnia, Obesity), Form (Creams, Gels, Oral Syrups), Distribution - Global Forecast 2024-2030
... reach USD 22.14 billion in 2024, at a CAGR 5.82% to reach USD 31.12 billion by 2030. Global Lifestyle Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Lifestyle Drugs ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Animal Biotechnology Market by Product (Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs), Application (Development of Animal Pharmaceuticals, Food Safety & Drug Development, Preventive Care for Animals) - Global Forecast 2024-2030
... was estimated at USD 28.64 billion in 2023 and expected to reach USD 31.04 billion in 2024, at a CAGR 8.46% to reach USD 50.59 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Eczema Therapeutics Market by Treatment (Antibiotics, Antihistamines, Calcineurin Inhibitors), Distribution Channel (Hospital & Clinics, Online Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... and expected to reach USD 7.49 billion in 2024, at a CAGR 9.59% to reach USD 13.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Eczema Therapeutics Market. ... Read More
-
Parkinson's Disease Therapeutics Market by Type (Intestinal Infusion, Oral, Subcutaneous), Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor), Distribution Channel, End Use - Global Forecast 2024-2030
... 3.15 billion in 2023 and expected to reach USD 3.49 billion in 2024, at a CAGR 10.88% to reach USD 6.51 billion by 2030. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market FPNV Positioning Matrix The FPNV ... Read More
-
Cell Cryopreservation Market - By Product Type (Cryoprotectant Agents, Equipment), Cell Type (Stem Cells, Oocytes & Embryotic Cells, Sperm Cells), Application (Drug Discovery & Development, Regenerative Medicine), End-use - Global Forecast, 2024 - 2032
... Cell Cryopreservation Market will register a 21.5% CAGR from 2024 to 2032 due to advancements in biobanking technologies and the expanding applications of stem cell research. With the launch of new laboratories, there's an increased ... Read More
-
Gastroesophageal Reflux Disease Therapeutics Market by Type (Branded, Generics), Drug Class (Aminosalicylates, Anti-Diarrheal, Anti-Emetics), Application - Global Forecast 2024-2030
... expected to reach USD 6.14 billion in 2024, at a CAGR 5.01% to reach USD 8.24 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Gastroesophageal Reflux Disease Therapeutics ... Read More
-
Label-free Array System Market by Technique (Atomic Force Microscopy, Ellipsometry Techniques, Enthalpy Array), Application (Biomolecular Interactions, Detection of Disease Biomarkers, Drug Discovery), End User - Global Forecast 2024-2030
... estimated at USD 1.38 billion in 2023 and expected to reach USD 1.49 billion in 2024, at a CAGR 8.11% to reach USD 2.38 billion by 2030. Global Label-free Array System Market FPNV Positioning Matrix ... Read More
-
Dementia Drugs Market by Indications (Alzheimer's Disease, Lewy Body Dementia, Parkinsons Disease Dementia), Drug Class (Cholinesterase Inhibitors, Glutamate Inhibitors, MAO Inhibitors) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 10.78 billion in 2024, at a CAGR 10.39% to reach USD 19.58 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Antiviral Drugs Market by Drug Type (Branded Drugs, Generic Drugs), Therapeutics (Acquired Immunodeficiency Syndrome Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics), End Use - Global Forecast 2024-2030
... at USD 56.22 billion in 2023 and expected to reach USD 59.84 billion in 2024, at a CAGR 6.54% to reach USD 87.61 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Prostate Cancer Therapeutics Market by Drug Class (Chemotherapy, Hormonal Therapy, Immunotherapy), Distribution Channel (Drug Stores & Retail Pharmacies, Hospitals Pharmacies, Online Pharmacies) - Global Forecast 2024-2030
... USD 10.00 billion in 2023 and expected to reach USD 10.62 billion in 2024, at a CAGR 6.32% to reach USD 15.36 billion by 2030. Global Prostate Cancer Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Bioinformatics Market by Product (Bioinformatics Platform, Bioinformatics Services, Knowledge Management Tools), Application (Chemoinformatics, Genomics, Metabolomics), End-User - Global Forecast 2024-2030
... reach USD 32.03 billion in 2024, at a CAGR 18.51% to reach USD 88.84 billion by 2030. Global Bioinformatics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioinformatics Market. It ... Read More
-
Companion Animal Postoperative Pain Management Therapeutics Market by Product (Anesthetics, NSAIDs, Opioids), Animal Type (Canine, Feline) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 149.46 million in 2024, at a CAGR 10.05% to reach USD 265.74 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Companion ... Read More
-
Autoimmune Disease Drugs Market by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases), Drug Class (Anti-Inflammatory, Antihyperglycemic, Immunosuppressants), Distribution - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 116.79 billion in 2024, at a CAGR 7.52% to reach USD 180.67 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Polycystic Ovarian Syndrome Treatment Market by Drug Class (Anti-Depressants, Anti-Obesity, Insulin Sensitizing Agents), Surgery (Laparoscopic Ovarian Drilling, Ovarian Wedge Resection), Distribution Channel - Global Forecast 2024-2030
... at USD 3.25 billion in 2023 and expected to reach USD 3.45 billion in 2024, at a CAGR 6.63% to reach USD 5.09 billion by 2030. Global Polycystic Ovarian Syndrome Treatment Market FPNV Positioning Matrix ... Read More
-
Tuberculosis Drugs Market by Disease (Active TB, Latent TB), Drug Class (Combination Drugs, First-line Anti-TB Drugs, Second-line Anti-TB Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.04 billion in 2024, at a CAGR 6.28% to reach USD 2.95 billion by 2030. Global Tuberculosis Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Molecular Biology Enzymes & Kits & Reagents Market by Type (Enzymes, Kits, Reagents), Application (Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction), End-User - Global Forecast 2024-2030
... Market size was estimated at USD 19.14 billion in 2023 and expected to reach USD 21.35 billion in 2024, at a CAGR 11.88% to reach USD 42.02 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
-
Pharmacogenomics Market by Technology (DNA Sequencing, Electrophoresis, Mass Spectrometry), Application (Drug Discovery, Neurology, Oncology) - Global Forecast 2024-2030
... 9.10 billion in 2024, at a CAGR 5.97% to reach USD 12.73 billion by 2030. Global Pharmacogenomics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Pharmacogenomics Market. It offers a ... Read More
-
Clinical Research Services Market by Services (Clinical Trials, Diagnostic Research, Drug Development Consultancy), Indication (Cardio Vascular Disorders, CNS Disorders, Diabetes), End-User, Deployment - Global Forecast 2024-2030
... USD 57.31 billion in 2023 and expected to reach USD 62.69 billion in 2024, at a CAGR 9.47% to reach USD 108.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Critical Care Therapeutics Market by Drug Class (Albumin, Antithrombin Concentrates, Factor XIII Concentrates), Application (Acute Coronary Syndrome, Atrial Fibrillation, Coronary Angioplasty) - Global Forecast 2024-2030
... 4.77 billion in 2023 and expected to reach USD 5.03 billion in 2024, at a CAGR 5.39% to reach USD 6.90 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Fetal Bovine Serum Market by Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum), Application (Cell Culture Media, Diagnostics, Drug Discovery), End-User - Global Forecast 2024-2030
... 1.02 billion in 2023 and expected to reach USD 1.08 billion in 2024, at a CAGR 6.44% to reach USD 1.58 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Microbiome Therapeutics Market by Type (FMT, Microbiome Drugs), Application (C. difficile, Crohn’s disease, Diabetes) - Global Forecast 2024-2030
... USD 156.40 million in 2024, at a CAGR 23.77% to reach USD 564.82 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Microbiome Therapeutics Market. It offers a comprehensive ... Read More
-
Gout Therapeutics Market by Drug Class (Colchicine, Corticosteroids, NSAIDs), Treatment (Uricosuria Medication, Xanthine Oxidase Inhibitor), Route of Administration, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 3.05 billion in 2024, at a CAGR 10.95% to reach USD 5.70 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Gout Therapeutics ... Read More
-
Aptamers Market by Product (Nucleotide Based, Peptide Based), Application (Diagnostics, Research & Development, Therapeutics Development), End-User - Global Forecast 2024-2030
... reach USD 1.48 billion in 2024, at a CAGR 10.91% to reach USD 2.77 billion by 2030. Aptamers are single-stranded oligonucleotides, including DNA, RNA, or modified nucleic acids, that have the ability to bind specifically ... Read More
Research Assistance
